Q3 2018 Tetraphase Pharmaceuticals Inc Earnings Call

8/11/2018 16:30

Llamada en conferencia Tetraphase Pharmaceuticals Inc

Tetraphase Pharmaceuticals Inc Conference call or earnings call will be held on 08-nov-2018
During the earnings conference call’s session, Tetraphase Pharmaceuticals Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Tetraphase Pharmaceuticals Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a clinical-stage biopharmaceutical company using our proprietary chemistry technology to create novel antibiotics for serious and life-threatening multidrug-resistant infections. We are developing our lead product candidate, eravacycline, a fully synthetic tetracycline derivative, as a broad-spectrum intravenous, or IV, and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant Gram-negative infections. We conducted a global phase 3 clinical program for eravacycline called IGNITE (Investigating Gram-Negative Infections Treated with Eravacycline), consisting of two phase 3 clinical trials.    
Leer más Llamada en conferencia

Tetraphase Pharmaceuticals Inc (TTPH)

480 Arsenal Street, Watertown Massachusetts 02472, United States